RxDoctor Payments Data

Rosa Gomez, MD

Family Medicine · Palmdale, CANPI 1801919220

Payments from drug & device makers

$1,954in general payments, 2019–2025

Across 92 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$664
  • Novo Nordisk$287
  • Boehringer Ingelheim$226
  • GSK$195
  • Bayer$97
  • Merck$90
  • plus $395 from 13 others

What the payments were for

  • Food & beverage$1,93999%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,954 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$11,271
Medicare patients
63
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin69$99,157
EliquisApixaban32$38,677
OzempicSemaglutide29$32,133
TrulicityDulaglutide12$28,536
RybelsusSemaglutide13$27,524
JanuviaSitagliptin Phosphate23$25,380
FarxigaDapagliflozin Propanediol12$18,912
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$8,424
Spiriva RespimatTiotropium Bromide14$6,961
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$5,593
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$4,555
Albuterol Sulfate HfaAlbuterol Sulfate108$3,112
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$2,750
Atorvastatin Calcium250$2,389
Losartan Potassium203$2,017

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$226$106,11883 claims
Novo NordiskOzempic, Rybelsus$287$59,65742 claims
PfizerEliquis$12$38,67732 claims
Lilly USA, LLCTrulicity$15$28,53612 claims
MerckJanuvia$90$25,38023 claims
AstraZenecaFarxiga$63$18,91212 claims
GSKTrelegy Ellipta, Anoro Ellipta$195$14,01728 claims
AbbVieSynthroid$37$1,31414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.

Other family medicine in Palmdale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →